Oxidative stress and nitric oxide deficiency in inflammation of chronic renal failure: Possible preventive role of L-arginine and multiple antioxidants

Saudi Medical Journal

Volumn 30, Issue 9, 2009, Pages 1150-1157

  Korish, Aida A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; ASCORBIC ACID; CARNITINE; CATECHIN; CHOLESTEROL; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LIPID; NITRATE; NITRIC OXIDE; NITRITE; NITROGEN DIOXIDE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DRUG ACTIVITY; DYSLIPIDEMIA; HYPERTENSION; KIDNEY FUNCTION; MALE; NEPHRITIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIOXIDANTS; ARGININE; INFLAMMATION; INFLAMMATION MEDIATORS; KIDNEY FAILURE, CHRONIC; MALE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 70449722888     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Mendoza MG, Castillo-Henkel C, Medina-Santillan R, Jarillo Luna RA, Robles HV, Romo E, et al. Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase -/- mice and improved by combined administration of L-arginine and antioxidants. Nephrology (Carlton) 2008; 13: 218-227. (Pubitemid 351341459)
2. Taylor BS,Geller DA. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 2000; 13: 413-424.
3. Nieves Jr C, Langkamp-Henken B. Arginine and immunity: a unique perspective. Biomed Pharmacother 2002; 56: 471-482.
4. Himmelfarb J, Stenvinkel P, Ikizler TA. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-1538.
5. Descamps-Latscha B, Drueke T, Witko-Sarsat V. Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy. Semin Dial 2001; 14: 193-199. (Pubitemid 33720852)
6. Guarnieri G, Situlin R, Biolo G. Carnitine metabolism in uremia. Am J Kidney Dis 2001; 38: S63-S67.
7. Savica V, Santo D, Ciolino F. L-carnitine infusions may suppress serum C- reactive protein and improve nutritional status in maintenance hem dialysis patients. J Renal Nutr 2005; 15: 225-230. (Pubitemid 40502092)
8. Guarnieri G, Biolo G, Vinci P, Massolino B, Barazzoni R. Advances in carnitine in chronic uremia. J Ren Nutr 2007; 17: 23-29.
9. Yang CS, Hong J, Hou Z, Sang S. Green tea polyphenols: antioxidative and prooxidative effects. J Nutr 2004; 134: 3181S. (Pubitemid 39470106)
10. Oslen JL. Role of heparin as a protective agent following reduction of renal mass. Kidney Int 1993; 44: 445-450.
11. Green LC, Wanger DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate & nitrite and (15N) nitrate in biological fluids. Anal Biochem 1982; 126: 131-138. (Pubitemid 13203451)
12. Bevc S, Sabic S, Hojs R. Atherosclerosis in hemodialysis patients -the role of microinflammation. Ren Fail 2008; 30: 1012-1016.
13. Korish AA, Maha M. Arafah. Catechin combined with vitamins C and E ameliorates insulin resistance (IR) and atherosclerotic changes in aged rats with chronic renal failure (CRF). Arch Gerontol Geriatrics 2008; 46: 25-39.
14. Baylis C.Nitric oxide deficiency in chronic kidney disease. Am J Physiol 2008; 294: F1-F9.
15. Göçmen AY, Sahin E, Koçak H, Tuncer M, Gümüşlü S. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment. Clin Biochem 2008; 41: 836-840.
16. Bonomini M, Sirolli V, Di Pietro N, Pandolfi A. Reduced nitric oxide bioavailability in chronic renal failure: a new factor of progression? G Ital Nefrol 2008; 25: 306-316.
17. Siani A, Pagana E, Lacone R, Lacoviello L. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am J Hypertens 2000; 13: 547-551. (Pubitemid 30330719)
18. Dumont Y, D'Amours M, Lebel M, Lariviere R. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats. Nephrol Dial Transplant 2001; 16: 746-754. (Pubitemid 32257970)
19. El-Mesallamy HO, Abdel Hamid SG, Gad MZ. Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake. Kidney Blood Press Res 2008; 31: 189-195.
20. Boger RH. Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Explains the "L-arginine Paradox" and Acts as a Novel Cardiovascular Risk Factor. J Nutr 2004; 134 (10Suppl): 2842S-2847S.
21. Peters H, Border WA, Noble NA. Tandem antifibrotic action of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis. Kidney Int 2000; 57: 992-1001. (Pubitemid 30434789)
22. Sydow K, Schwedhelm E, Arakawa N. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inenia: effects of L-arginine and B vitamins. Cardiovascular Research 2003; 57: 244-252. (Pubitemid 36009457)
23. Korish AA, Arafah MM. The potential anti-inflammatory effect of tetrahydrobiopetrin administration in renal mass reduction -induced chronic renal failure in rats. Saudi Med J 2007; 28: 1803-1809.
24. Stonvinkel P, Lindholm B, Heimburger M, Heimburger O. Elevated serum levels of soluble adhesion molecules predicted death in pre-dialysis patients: association with malnutrition, inflammation and, cardiovascular disease. Nephrol Dial Transplant 2000; 15: 1624-1630. (Pubitemid 30763223)
25. Vaccaro F, Mulè G, Cottone S, Soresi M, Giannitrapani L, Vadalà A, et al. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein. Arch Med Res 2007; 38: 534-538. (Pubitemid 46873808)
26. Papayianni A, Alexopoulos E, Giamalis P, Gionanlis L, Belechri AB, Koukoudis P, et al. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association within inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transplant 2002; 17: 435-441. (Pubitemid 34211140)
27. Perunicic-Pekovic G, Pljesa S, Rasic-Milutinovic Z, Stankovic S, Ilic M, Maletic R. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients. Can J Physiol Pharmacol 2008; 86: 205-209.
28. Chung AS, Gao Q, Kao WJ. Either integrin subunit beta-1 or beta-3 is involved in mediating monocyte adhesion, IL-1beta protein and mRNA expression in response to surfaces functionalized with fibronectin-derived peptides. J Biomater Sci Polym Ed 2007; 18: 713-729.
29. Lindemann S, Sharaf M, Spiecker M, Buerke M, Fisch A, Grosser T. NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1mRNA and surface expression. Thromb Res 2000; 97: 113-123. (Pubitemid 30055276)
30. Maccarrone M, Meloni C, Manca-di-Villahermosa S, Cococcetta N, Casciani CU, Finazzi-Agrò A, et al. Vitamin E suppressed 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route. Am J Kidney Dis 2001; 37: 964-969. (Pubitemid 32436568)
31. Yousef MI, Awad TI, Elhag FA, Khaled FA. Study of the protective effect of ascorbic acid against the toxicity of stannous chloride on oxidative damage, antioxidant enzymes and biochemical parameters in rabbits. Toxicology 2007; 235: 194-202.
32. El-Metwally TH, Hamed EA, Ahmad AR, Mohamed NA. Dyslipidemia, oxidative stress and cardiac dysfunction in children with chronic renal failure: effects of L-carnitine supplementation. Ann Saudi Med 2003; 23: 270-277.
33. Abrass CK. Lipid metabolism and renal disease. Contrib Nephrol 2006; 151: 106-121.
34. Rossi M, Carpi A, Di Maria C, Franzoni F, Galetta F, Santoro G. Skin blood flowmotion and microvascular reactivity investigation in hypercholesterolemic patients without clinically manifest arterial diseases. Physiol Res 2009; 58: 39-47.
35. Sokolovic D, Bjelakovic G, Nikolic J, Djindjic B, Pavlovic D, Kocic G, et al. Effect of L-arginine on metabolism of polyamines in rat's brain with extrahepatic cholestasis. Amino Acids 2009; Mar 13. [Epub ahead of print].
36. Ramesh E, Elanchezhian R, Sakthivel M, Jayakumar T, Senthil Kumar RS, Geraldine P, et al. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet. Fundam Clin Pharmacol 2008; 22: 275-284. (Pubitemid 351712896)
37. Malaguarnera M, Vacante M, Avitabile T, Malaguarnera M, Cammalleri L, Motta M.L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. Am J Clin Nutr 2009; 89: 71-76.
38. Siani A, Pagano E, Lacone R, Lacoviello L. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am J Hypertens 2000; 13: 547-551. (Pubitemid 30330719)